Bristol Myers Squibb (CELG-RI) Inventory (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has 18 years of Inventory data on file, last reported at $2.8 billion in Q1 2026.

• Inventory for Q1 2026 came in at $2.8 billion, up 3.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 billion (up 3.38% YoY), and the FY2025 annual result was $2.7 billion, up 5.2% from the prior year.
• Inventory grew to $2.8 billion in Q1 2026 per CELG-RI's latest filing, from $2.7 billion in the prior quarter.
• Over five years, Inventory peaked at $3.3 billion in Q3 2024 and troughed at $2.1 billion in Q3 2022.
• A 5-year average of $2.6 billion and a median of $2.7 billion in 2023 frame the typical range for Inventory.
• The sharpest annual moves came in 2024 and 2025: Inventory soared 36.78% in 2024, then dropped 17.23% in 2025.
• A 5-year view of Inventory shows it stood at $2.3 billion in 2022, then rose by 13.81% to $2.7 billion in 2023, then decreased by 3.94% to $2.6 billion in 2024, then increased by 5.2% to $2.7 billion in 2025, then gained by 2.45% to $2.8 billion in 2026.
• Business Quant data shows CELG-RI's Inventory at $2.8 billion in Q1 2026, $2.7 billion in Q4 2025, and $2.8 billion in Q3 2025.